• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Faricimab Resolves Refractory Macular Edema in Two UGH Syndrome Cases

by
November 19, 2026
in Health
Reading Time: 2 mins read
0
Faricimab Resolves Refractory Macular Edema in Two UGH Syndrome Cases

Faricimab Resolves Refractory Macular Edema in Two UGH Syndrome Cases

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Intravitreal faricimab resulted in favorable anatomical and functional recovery for two patients presenting with persistent cystoid macular edema secondary to uveitis-glaucoma-hyphema syndrome, according to clinical findings published in the Journal of Ophthalmic Inflammation and Infection. The peer-reviewed report documents the successful resolution of fluid accumulation alongside measurable improvements in visual acuity following administration of the medication.

The initial protocols incorporated topical nonsteroidal anti-inflammatory drugs, topical corticosteroids, and targeted periocular corticosteroid injections. Despite these multiple interventions, neither patient achieved anatomical resolution of the cystoid macular edema, which remained persistent.

To avoid the risks associated with corticosteroid-induced ocular hypertension, each patient subsequently received a single intravitreal injection of faricimab. Following the procedure, both individuals experienced complete anatomical resolution of their cystoid macular edema, coupled with documented improvements in visual acuity and sustained anatomical stability throughout post-treatment follow-up examinations.

In their published conclusion, lead author Georgios Batsos and the research team highlighted that intravitreal faricimab demonstrated positive functional and anatomical outcomes in both refractory cases. The authors suggested that faricimab represents a viable alternative treatment strategy for persistent macular edema in selected patients whose therapeutic options are constrained by coexisting ocular disease.

Subject of Research: Intravitreal faricimab treatment for persistent cystoid macular edema secondary to uveitis-glaucoma-hyphema syndrome

Article Title: Intravitreal faricimab for refractory macular edema associated with uveitis-glaucoma-hyphema syndrome: a report of two cases

Article References: Batsos, G., Kontomichos, L., Karagiannis, D., Christou, E. E., Christodoulou, E., Bouratzis, N., & Paroikakis, E. (2026). Intravitreal faricimab for refractory macular edema associated with uveitis-glaucoma-hyphema syndrome: a report of two cases. Journal of Ophthalmic Inflammation and Infection. https://doi.org/10.1186/s12348-026-00633-7

Image Credits: AI Generated

DOI: 10.1186/s12348-026-00633-7

Keywords: faricimab, intravitreal injection, macular edema, cystoid macular edema, uveitis-glaucoma-hyphema syndrome, UGH syndrome, intraocular lens, sulcus implantation, iris chafing, glaucoma, intraocular pressure, visual acuity, ophthalmology, retina, corticosteroids, case report

News Source: Ophelia Keating. (November 19, 2026). Faricimab Resolves Refractory Macular Edema in Two UGH Syndrome Cases. Scienmag.

Tags: case reportcorticosteroidscystoid macular edemafaricimabglaucomaintraocular lensintraocular pressureintravitreal injectioniris chafingmacular edemaOphthalmologyRetinasulcus implantationUGH syndromeuveitis-glaucoma-hyphema syndromevisual acuity
Share12Tweet7Share2ShareShareShare1

Related Posts

Dutch Mental Healthcare Collaboration Faces Deep Mistrust Rooted in Market Reforms

Dutch Mental Healthcare Collaboration Faces Deep Mistrust Rooted in Market Reforms

November 19, 2026
Neural Network Accurately Predicts Drug Release Kinetics in Simulated Polymeric Formulations

Neural Network Accurately Predicts Drug Release Kinetics in Simulated Polymeric Formulations

November 19, 2026

Pathology Conference Unveils Advances in Organoids, Oncology, and Digital Diagnostics

November 19, 2026

Streamlined YOLO11n Network Enables Rapid Automated Monitoring of Sow Nursing Behavior

November 19, 2026

POPULAR NEWS

  • Anlotinib Combined with Cranial Radiotherapy Shows Promise for Lung Cancer Brain Metastases

    Anlotinib Combined with Cranial Radiotherapy Shows Promise for Lung Cancer Brain Metastases

    29 shares
    Share 12 Tweet 7
  • Curcumin Reduces Liver Steatosis in Rats by Altering Gut Microbiota and Epigenetics

    29 shares
    Share 12 Tweet 7
  • Air Sampling in Bat Caves Captures Mammalian Viruses Across Optimized Volumes

    29 shares
    Share 12 Tweet 7
  • Rimegepant Provides Meaningful Relief as Second- or Third-Line Acute Migraine Therapy

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Dutch Mental Healthcare Collaboration Faces Deep Mistrust Rooted in Market Reforms

Neural Network Accurately Predicts Drug Release Kinetics in Simulated Polymeric Formulations

Pathology Conference Unveils Advances in Organoids, Oncology, and Digital Diagnostics

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.